If you have any of these below questions, please read the shareholder update from Tom Allinder the CEO of RFMK. The update is a sticky note.
Why the recent change of management positions? Who's who now, and what is their responsibility moving forward? How will long term funding be handled? Will there be dilution? Actually, see March 16 PR for that answer... Will RFMK bring other members to the team? Can Mike Amezquita (former CEO still with company) sell his shares? Is the new Cannacig still on track to be released this month (March 2012)? What about trademarks and patents?
Feel free to add other questions. These are just some that were addressed and answered. Interpret how you please.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.